4//SEC Filing
Dalvey David 4
Accession 0001437749-22-013130
CIK 0001603454other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:41 PM ET
Size
24.6 KB
Accession
0001437749-22-013130
Insider Transaction Report
Form 4
Celcuity Inc.CELC
Dalvey David
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2022-05-17−8,200→ 0 totalExercise: $16.23Exp: 2027-10-19→ Common Stock (8,200 underlying) - Award
Stock Option (right to buy)
2022-05-17+8,200→ 8,200 totalExercise: $5.50Exp: 2027-10-19→ Common Stock (8,200 underlying) - Disposition to Issuer
Stock Option (right to buy)
2022-05-17−3,201→ 0 totalExercise: $19.45Exp: 2028-05-14→ Common Stock - Award
Stock Option (right to buy)
2022-05-17+3,201→ 3,201 totalExercise: $5.50Exp: 2028-05-14→ Common Stock (3,201 underlying) - Disposition to Issuer
Stock Option (right to buy)
2022-05-17−5,054→ 0 totalExercise: $22.45Exp: 2029-05-16→ Common Stock (5,054 underlying) - Award
Stock Option (right to buy)
2022-05-17+5,054→ 5,054 totalExercise: $5.50Exp: 2029-05-16→ Common Stock (5,054 underlying) - Disposition to Issuer
Stock Option (right to buy)
2022-05-17−2,310→ 0 totalExercise: $26.99Exp: 2031-05-12→ Common Stock (2,310 underlying) - Award
Stock Option (right to buy)
2022-05-17+2,310→ 2,310 totalExercise: $5.50Exp: 2031-05-12→ Common Stock (2,310 underlying) - Award
Stock Option (right to buy)
2022-05-17+24,449→ 24,449 totalExercise: $5.50Exp: 2032-05-17→ Common Stock (24,449 underlying)
Holdings
- 250,000(indirect: By Brightstone Venture Capital Fund, LP)
Common Stock
- 9,325
Common Stock
- 12,654
Stock Option (right to buy)
Exercise: $5.10Exp: 2030-05-14→ Common Stock (12,654 underlying)
Footnotes (4)
- [F1]The Reporting Person is the General Partner of Brightstone Venture Capital Fund, LP.
- [F2]100% vested.
- [F3]The transactions reported herein reflect a one-time stock option repricing (the "Option Repricing") effective on May 17, 2022 and are being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934. Pursuant to the Option Repricing, the exercise price of the Stock Option has been amended to reduce such exercise price to $5.50 per share, the closing price of the issuer's common stock on The Nasdaq Capital Market as of the date of such repricing. There have been no other changes to the terms of the Stock Option.
- [F4]This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.
Documents
Issuer
Celcuity Inc.
CIK 0001603454
Entity typeother
Related Parties
1- filerCIK 0001296457
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 8:41 PM ET
- Size
- 24.6 KB